Suppr超能文献

骨转移继发骨相关事件的健康状态效用值。

Health state utilities for skeletal-related events secondary to bone metastases.

作者信息

Matza Louis S, Chung Karen, Van Brunt Kate, Brazier John E, Braun Ada, Currie Brooke, Palsgrove Andrew, Davies Evan, Body Jean-Jacques

机构信息

Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD, 20814, USA,

出版信息

Eur J Health Econ. 2014 Jan;15(1):7-18. doi: 10.1007/s10198-012-0443-2. Epub 2013 Jan 25.

Abstract

INTRODUCTION

Patients with bone metastases often experience skeletal-related events (SREs). Although cost-utility models are used to examine treatments for metastatic cancer, limited information is available on utilities of SREs. The purpose of this study was to estimate the disutility of four SREs: spinal cord compression, pathological fracture, radiation to bone, and surgery performed to stabilize a bone.

METHODS

General population participants from the UK and Canada completed time trade-off (TTO) interviews to assess the utility of health states drafted based on literature review, clinician interviews, and patient interviews. Respondents first rated a health state describing cancer with bone metastases. Then, the SREs were added to this health state.

RESULTS

Interviews were completed with 187 participants (50.8 % male, 80.2 % white). Cancer with bone metastases without an SRE had a mean utility of 0.47 (SD = 0.43) on a standard utility scale (1 = full health, 0 = death). Of the SREs, spinal cord compression was associated with the greatest disutility (i.e., the utility decrease): -0.32 with paralysis and -0.22 without paralysis. Surgery had a disutility of -0.07. Leg, arm, and rib fractures had disutilities of -0.06, -0.04, and -0.03. Two weeks of daily radiation treatment had a disutility of -0.06, while two radiation appointments had the smallest impact on utility (-0.02).

CONCLUSION

All SREs were associated with statistically significant utility decreases, suggesting a perceived impact on quality of life beyond the impact of cancer with bone metastases. The resulting disutilities may be used in cost-utility models examining treatments to prevent SREs secondary to bone metastases.

摘要

引言

骨转移患者常经历骨相关事件(SREs)。尽管成本效用模型用于研究转移性癌症的治疗方法,但关于SREs效用的信息有限。本研究的目的是评估四种SREs的负效用:脊髓压迫、病理性骨折、骨放疗以及为稳定骨骼而进行的手术。

方法

来自英国和加拿大的普通人群参与者完成了时间权衡(TTO)访谈,以评估基于文献综述、临床医生访谈和患者访谈起草的健康状态的效用。受访者首先对描述伴有骨转移的癌症的健康状态进行评分。然后,将SREs添加到该健康状态中。

结果

对187名参与者进行了访谈(男性占50.8%,白人占80.2%)。在标准效用量表(1 = 完全健康,0 = 死亡)上,无SREs的伴有骨转移的癌症的平均效用为0.47(标准差 = 0.43)。在SREs中,脊髓压迫与最大的负效用相关(即效用降低):瘫痪时为 -0.32,无瘫痪时为 -0.22。手术的负效用为 -0.07。腿部、手臂和肋骨骨折的负效用分别为 -0.06、-0.04和 -0.03。两周的每日放疗负效用为 -0.06,而两次放疗预约对效用的影响最小(-0.02)。

结论

所有SREs均与统计学上显著的效用降低相关,表明其对生活质量的影响被认为超过了伴有骨转移的癌症的影响。由此产生的负效用可用于成本效用模型,以研究预防骨转移继发SREs的治疗方法。

相似文献

引用本文的文献

5
Health state utility values by cancer stage: a systematic literature review.癌症分期的健康状态效用值:系统文献回顾。
Eur J Health Econ. 2021 Nov;22(8):1275-1288. doi: 10.1007/s10198-021-01335-8. Epub 2021 Jun 14.

本文引用的文献

5
Health utility estimation.健康效用值评估。
Expert Rev Pharmacoecon Outcomes Res. 2002 Apr;2(2):99-108. doi: 10.1586/14737167.2.2.99.
7
Valuing health States for use in cost-effectiveness analysis.评估用于成本效益分析的健康状态。
Pharmacoeconomics. 2008;26(9):769-79. doi: 10.2165/00019053-200826090-00007.
8
How consistent are health utility values?
Qual Life Res. 2008 Sep;17(7):1031-42. doi: 10.1007/s11136-008-9368-8. Epub 2008 Aug 8.
9
Utilities and disutilities for type 2 diabetes treatment-related attributes.2型糖尿病治疗相关属性的效用和负效用。
Qual Life Res. 2007 Sep;16(7):1251-65. doi: 10.1007/s11136-007-9226-0. Epub 2007 Jul 19.
10
Tumor metastasis to bone.肿瘤骨转移。
Arthritis Res Ther. 2007;9 Suppl 1(Suppl 1):S5. doi: 10.1186/ar2169.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验